| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
|
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1
|
|
ABCF2
|
ATP-binding cassette, sub-family F (GCN20), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABHD6
|
abhydrolase domain containing 6
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain
|
|
ACAN
|
aggrecan
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACD
|
adrenocortical dysplasia homolog (mouse)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACRBP
|
acrosin binding protein
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD3
|
adducin 3 (gamma)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AEBP1
|
AE binding protein 1
|
|
AFF2
|
AF4/FMR2 family, member 2
|
|
AFP
|
alpha-fetoprotein
|
|
AGAP1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGMO
|
alkylglycerol monooxygenase
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AHSP
|
alpha hemoglobin stabilizing protein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIPL1
|
aryl hydrocarbon receptor interacting protein-like 1
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALPPL2
|
alkaline phosphatase, placental-like 2
|
|
AMELY
|
amelogenin, Y-linked
|
|
AMH
|
anti-Mullerian hormone
|
|
AMN
|
amnion associated transmembrane protein
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO5
|
anoctamin 5
|
|
ANOS1
|
anosmin 1
|
|
ANP32C
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member C
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit
|
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARG2
|
arginase 2
|
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like)
|
|
ARL15
|
ADP-ribosylation factor-like 15
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN1
|
ataxin 1
|
|
ATXN10
|
ataxin 10
|
|
ATXN8OS
|
ATXN8 opposite strand (non-protein coding)
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BAX
|
BCL2-associated X protein
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BEST3
|
bestrophin 3
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BOLL
|
boule-like RNA-binding protein
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRI3
|
brain protein I3
|
|
BSG
|
basigin (Ok blood group)
|
|
BTBD9
|
BTB (POZ) domain containing 9
|
|
BTN2A1
|
butyrophilin, subfamily 2, member A1
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BUD13
|
BUD13 homolog (S. cerevisiae)
|
|
C10ORF10
|
chromosome 10 open reading frame 10
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAGE1
|
cancer antigen 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN10
|
calpain 10
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CBX3
|
chromobox homolog 3
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNB1
|
cyclin B1
|
|
CCNB2
|
cyclin B2
|
|
CCNC
|
cyclin C
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCT3
|
chaperonin containing TCP1, subunit 3 (gamma)
|
|
CD14
|
CD14 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD48
|
CD48 molecule
|
|
CD52
|
CD52 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2A-AS1
|
CDKN2A antisense RNA 1 (head to head)
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPJ
|
centromere protein J
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CERKL
|
ceramide kinase-like
|
|
CES1
|
carboxylesterase 1
|
|
CES2
|
carboxylesterase 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFHR4
|
complement factor H-related 4
|
|
CFHR5
|
complement factor H-related 5
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGB
|
chromogranin B
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHN1
|
chimerin 1
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CILP
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLDN7
|
claudin 7
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL15A1
|
collagen, type XV, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL26A1
|
collagen, type XXVI, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPA
|
coatomer protein complex, subunit alpha
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPA4
|
carboxypeptidase A4
|
|
CPNE1
|
copine I
|
|
CPSF1
|
cleavage and polyadenylation specific factor 1, 160kDa
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CRELD1
|
cysteine-rich with EGF-like domains 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG5
|
chondroitin sulfate proteoglycan 5 (neuroglycan C)
|
|
CST3
|
cystatin C
|
|
CT45A1
|
cancer/testis antigen family 45, member A1
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAG2
|
cancer/testis antigen 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CTSK
|
cathepsin K
|
|
CTSS
|
cathepsin S
|
|
CTSW
|
cathepsin W
|
|
CTTN
|
cortactin
|
|
CTXN3
|
cortexin 3
|
|
CUL3
|
cullin 3
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAOA-AS1
|
DAOA antisense RNA 1
|
|
DARS2
|
aspartyl-tRNA synthetase 2, mitochondrial
|
|
DAXX
|
death-domain associated protein
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DAZ2
|
deleted in azoospermia 2
|
|
DAZ3
|
deleted in azoospermia 3
|
|
DAZ4
|
deleted in azoospermia 4
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein
|
|
DCD
|
dermcidin
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103A
|
defensin, beta 103A
|
|
DEFB104A
|
defensin, beta 104A
|
|
DEFB105A
|
defensin, beta 105A
|
|
DEFB105B
|
defensin, beta 105B
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DHDH
|
dihydrodiol dehydrogenase (dimeric)
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DMD
|
dystrophin
|
|
DMRT1
|
doublesex and mab-3 related transcription factor 1
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNM1L
|
dynamin 1-like
|
|
DNM2
|
dynamin 2
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOCK9
|
dedicator of cytokinesis 9
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DSC2
|
desmocollin 2
|
|
DSG2
|
desmoglein 2
|
|
DSP
|
desmoplakin
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DYNLRB2
|
dynein, light chain, roadblock-type 2
|
|
DYSF
|
dysferlin
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F6
|
E2F transcription factor 6
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECE2
|
endothelin converting enzyme 2
|
|
EDA
|
ectodysplasin A
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDN1
|
endothelin 1
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EHD2
|
EH-domain containing 2
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELN
|
elastin
|
|
ELOVL5
|
ELOVL fatty acid elongase 5
|
|
EMD
|
emerin
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENTPD6
|
ectonucleoside triphosphate diphosphohydrolase 6 (putative)
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC8
|
excision repair cross-complementation group 8
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EVC2
|
Ellis van Creveld syndrome 2
|
|
EVL
|
Enah/Vasp-like
|
|
EXO1
|
exonuclease 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBN1
|
fibrillin 1
|
|
FBXO2
|
F-box protein 2
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRLA
|
Fc receptor-like A
|
|
FDPS
|
farnesyl diphosphate synthase
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FFAR2
|
free fatty acid receptor 2
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF20
|
fibroblast growth factor 20
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGG
|
fibrinogen gamma chain
|
|
FGL2
|
fibrinogen-like 2
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKTN
|
fukutin
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO3
|
forkhead box O3
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FRZB
|
frizzled-related protein
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FSIP1
|
fibrous sheath interacting protein 1
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXN
|
frataxin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAK
|
cyclin G associated kinase
|
|
GALE
|
UDP-galactose-4-epimerase
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GARS
|
glycyl-tRNA synthetase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GBA
|
glucosidase, beta, acid
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF9
|
growth differentiation factor 9
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GINS3
|
GINS complex subunit 3 (Psf3 homolog)
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GKN3P
|
gastrokine 3, pseudogene
|
|
GLB1
|
galactosidase, beta 1
|
|
GLO1
|
glyoxalase I
|
|
GLRX5
|
glutaredoxin 5
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNAS
|
GNAS complex locus
|
|
GNAS-AS1
|
GNAS antisense RNA 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOPC
|
golgi-associated PDZ and coiled-coil motif containing
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP2
|
glycoprotein 2 (zymogen granule membrane)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPC3
|
glypican 3
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPR174
|
G protein-coupled receptor 174
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
|
GRK4
|
G protein-coupled receptor kinase 4
|
|
GRK6
|
G protein-coupled receptor kinase 6
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GTF2H5
|
general transcription factor IIH, polypeptide 5
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC9
|
histone deacetylase 9
|
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPH3
|
heterogeneous nuclear ribonucleoprotein H3 (2H9)
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA1
|
homeobox A1
|
|
HOXA11
|
homeobox A11
|
|
HOXA13
|
homeobox A13
|
|
HOXA2
|
homeobox A2
|
|
HOXA9
|
homeobox A9
|
|
HOXB13
|
homeobox B13
|
|
HOXC9
|
homeobox C9
|
|
HP
|
haptoglobin
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPS1
|
Hermansky-Pudlak syndrome 1
|
|
HPS4
|
Hermansky-Pudlak syndrome 4
|
|
HPS5
|
Hermansky-Pudlak syndrome 5
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTN1
|
histatin 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDS
|
iduronate 2-sulfatase
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IFNW1
|
interferon, omega 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IGHV4-34
|
immunoglobulin heavy variable 4-34
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21R
|
interleukin 21 receptor
|
|
IL23R
|
interleukin 23 receptor
|
|
IL31
|
interleukin 31
|
|
IL32
|
interleukin 32
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
INVS
|
inversin
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRX4
|
iroquois homeobox 4
|
|
ISCU
|
iron-sulfur cluster assembly enzyme
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
IVL
|
involucrin
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JTB
|
jumping translocation breakpoint
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ15
|
potassium channel, inwardly rectifying subfamily J, member 15
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1217
|
KIAA1217
|
|
KIF3A
|
kinesin family member 3A
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF13
|
Kruppel-like factor 13
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLHL7
|
kelch-like family member 7
|
|
KLK15
|
kallikrein-related peptidase 15
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT1
|
keratin 1, type II
|
|
KRT10
|
keratin 10, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT8
|
keratin 8, type II
|
|
L1TD1
|
LINE-1 type transposase domain containing 1
|
|
LACRT
|
lacritin
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGI2
|
leucine-rich repeat LGI family, member 2
|
|
LGMN
|
legumain
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX3
|
LIM homeobox 3
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LINGO2
|
leucine rich repeat and Ig domain containing 2
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LIPC
|
lipase, hepatic
|
|
LIPG
|
lipase, endothelial
|
|
LIPH
|
lipase, member H
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LMNB2
|
lamin B2
|
|
LOR
|
loricrin
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRC7
|
leucine rich repeat containing 7
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LY96
|
lymphocyte antigen 96
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MATR3
|
matrin 3
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBP
|
myelin basic protein
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEIS1
|
Meis homeobox 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN1
|
mitofusin 1
|
|
MFN2
|
mitofusin 2
|
|
MFRP
|
membrane frizzled-related protein
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MIA
|
melanoma inhibitory activity
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106A
|
microRNA 106a
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR125B2
|
microRNA 125b-2
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR155
|
microRNA 155
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR199B
|
microRNA 199b
|
|
MIR200C
|
microRNA 200c
|
|
MIR204
|
microRNA 204
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR217
|
microRNA 217
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR27A
|
microRNA 27a
|
|
MIR31
|
microRNA 31
|
|
MIR378A
|
microRNA 378a
|
|
MIR423
|
microRNA 423
|
|
MIR433
|
microRNA 433
|
|
MIR486-1
|
microRNA 486-1
|
|
MIR499A
|
microRNA 499a
|
|
MIR539
|
microRNA 539
|
|
MIR708
|
microRNA 708
|
|
MIRLET7B
|
microRNA let-7b
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MLYCD
|
malonyl-CoA decarboxylase
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNS1
|
meiosis-specific nuclear structural 1
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MORF4L1
|
mortality factor 4 like 1
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MPZL1
|
myelin protein zero-like 1
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPS30
|
mitochondrial ribosomal protein S30
|
|
MS
|
multiple sclerosis
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MST1
|
macrophage stimulating 1
|
|
MSTN
|
myostatin
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUT
|
methylmalonyl CoA mutase
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYLK
|
myosin light chain kinase
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOCD
|
myocardin
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEUROG1
|
neurogenin 1
|
|
NEUROG3
|
neurogenin 3
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIA
|
nuclear factor I/A
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLGN3
|
neuroligin 3
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NPAS2
|
neuronal PAS domain protein 2
|
|
NPBWR1
|
neuropeptides B/W receptor 1
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NRG1
|
neuregulin 1
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTF3
|
neurotrophin 3
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP85
|
nucleoporin 85kDa
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLFM4
|
olfactomedin 4
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPN4
|
opsin 4
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORC6
|
origin recognition complex, subunit 6
|
|
ORM1
|
orosomucoid 1
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P3H2
|
prolyl 3-hydroxylase 2
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAH
|
phenylalanine hydroxylase
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PANK2
|
pantothenate kinase 2
|
|
PAPOLA
|
poly(A) polymerase alpha
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PBRM1
|
polybromo 1
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCDH15
|
protocadherin-related 15
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCOLCE
|
procollagen C-endopeptidase enhancer
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDE11A
|
phosphodiesterase 11A
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG3
|
paternally expressed 3
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PFN1
|
profilin 1
|
|
PGAM4
|
phosphoglycerate mutase family member 4
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PILRA
|
paired immunoglobin-like type 2 receptor alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD1L3
|
polycystic kidney disease 1-like 3
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
|
|
PLG
|
plasminogen
|
|
PLXNA2
|
plexin A2
|
|
PML
|
promyelocytic leukemia
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POMC
|
proopiomelanocortin
|
|
POMT2
|
protein-O-mannosyltransferase 2
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B
|
|
PQBP1
|
polyglutamine binding protein 1
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRNP
|
prion protein
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PROS1
|
protein S (alpha)
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN21
|
protein tyrosine phosphatase, non-receptor type 21
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
PYY
|
peptide YY
|
|
RAB22A
|
RAB22A, member RAS oncogene family
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD51D
|
RAD51 paralog D
|
|
RAET1E
|
retinoic acid early transcript 1E
|
|
RAET1L
|
retinoic acid early transcript 1L
|
|
RANGRF
|
RAN guanine nucleotide release factor
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF3
|
Ras association (RalGDS/AF-6) domain family member 3
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBM10
|
RNA binding motif protein 10
|
|
RBM12
|
RNA binding motif protein 12
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis)
|
|
RECQL4
|
RecQ protein-like 4
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
RFXAP
|
regulatory factor X-associated protein
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF213
|
ring finger protein 213
|
|
RNF31
|
ring finger protein 31
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPL10
|
ribosomal protein L10
|
|
RPS7
|
ribosomal protein S7
|
|
RPSA
|
ribosomal protein SA
|
|
RRP9
|
ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)
|
|
RTN2
|
reticulon 2
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A7A
|
S100 calcium binding protein A7A
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCAP
|
SREBF chaperone
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SEMA6B
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B
|
|
SENP5
|
SUMO1/sentrin specific peptidase 5
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD2
|
SET domain containing 2
|
|
SETMAR
|
SET domain and mariner transposase fusion gene
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPB
|
surfactant protein B
|
|
SFTPD
|
surfactant protein D
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIX2
|
SIX homeobox 2
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A17
|
solute carrier family 22, member 17
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC22A9
|
solute carrier family 22 (organic anion transporter), member 9
|
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC47A1
|
solute carrier family 47 (multidrug and toxin extrusion), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A7
|
solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAPIN
|
SNAP-associated protein
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPAST
|
spastin
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR2B
|
small proline-rich protein 2B
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SPTBN5
|
spectrin, beta, non-erythrocytic 5
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREK1
|
splicing regulatory glutamine/lysine-rich protein 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
SST
|
somatostatin
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STRC
|
stereocilin
|
|
STX1A
|
syntaxin 1A (brain)
|
|
STX6
|
syntaxin 6
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SVIL
|
supervillin
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYN3
|
synapsin III
|
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAGLN
|
transgelin
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TBX19
|
T-box 19
|
|
TBX21
|
T-box 21
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCN2
|
transcobalamin II
|
|
TCP1
|
t-complex 1
|
|
TECPR1
|
tectonin beta-propeller repeat containing 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFCP2
|
transcription factor CP2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM132D
|
transmembrane protein 132D
|
|
TMEM27
|
transmembrane protein 27
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS3
|
transmembrane protease, serine 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPO
|
thyroid peroxidase
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRB
|
T cell receptor beta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM26
|
tripartite motif containing 26
|
|
TRIM8
|
tripartite motif containing 8
|
|
TRO
|
trophinin
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB7P
|
tubulin, beta 7, pseudogene
|
|
TUBGCP6
|
tubulin, gamma complex associated protein 6
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMS
|
thymidylate synthetase
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBXN1
|
UBX domain protein 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCN
|
urocortin
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
ULBP3
|
UL16 binding protein 3
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP40
|
ubiquitin specific peptidase 40
|
|
VAPA
|
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WDFY2
|
WD repeat and FYVE domain containing 2
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XCL2
|
chemokine (C motif) ligand 2
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
YAP1
|
Yes-associated protein 1
|
|
YARS2
|
tyrosyl-tRNA synthetase 2, mitochondrial
|
|
YBX1
|
Y box binding protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZIC2
|
Zic family member 2
|
|
ZIC5
|
Zic family member 5
|
|
ZIM2
|
zinc finger, imprinted 2
|
|
ZNF143
|
zinc finger protein 143
|
|
ZNF432
|
zinc finger protein 432
|
|
ZPR1
|
ZPR1 zinc finger
|
